Upcoming ISG Provider Lens™ study will examine providers supporting industry transformation that delivers improved outcomes, cost reduction and regulatory complianceSTAMFORD, Conn.--(BUSINESS WIRE)--$III #AI--Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm, has launched a research study assessing providers of digital … [Read more...] about ISG to Evaluate Providers of Digital Healthcare Services
10Pearls Celebrates 6th Consecutive Year on the Inc. 5000 List
Persistent Growth and Innovation Earn 10Pearls a Spot Among America's Top Private CompaniesWASHINGTON--(BUSINESS WIRE)--Inc. revealed today that 10Pearls has been recognized on the 2024 Inc. 5000, its annual list of the fastest-growing private companies in America. The prestigious ranking provides a data-driven look at the most successful companies within the economy’s most … [Read more...] about 10Pearls Celebrates 6th Consecutive Year on the Inc. 5000 List
AtlasClear, Inc. to Participate in Seaport Financials and Fintech Conference on August 14
TAMPA, Fla.--(BUSINESS WIRE)--AtlasClear Holdings, Inc. (“AtlasClear Holdings”) (NYSE American: ATCH) today announced that Executive Chairman, John Schaible and President, Craig Ridenhour, will be participating in the Seaport Financials and Fintech Conference on Wednesday, August 14, 2024. Mr. Schaible and Mr. Ridenhour will also be hosting investor meetings that day. If you … [Read more...] about AtlasClear, Inc. to Participate in Seaport Financials and Fintech Conference on August 14
Core Scientific Announces Proposed Convertible Senior Notes Offering
AUSTIN, Texas--(BUSINESS WIRE)--$CORZ #aicloud--Core Scientific, Inc. (NASDAQ: CORZ) (“Core Scientific” or the “Company”), a leader in digital infrastructure for bitcoin mining and high-performance computing, today announced its intention to offer, subject to market and other conditions, $350.0 million aggregate principal amount of convertible senior notes due 2029 (the … [Read more...] about Core Scientific Announces Proposed Convertible Senior Notes Offering
Paysafe Reports Second Quarter 2024 Results; Raises Full Year Revenue Outlook
LONDON--(BUSINESS WIRE)--Paysafe Limited (“Paysafe” or the “Company”) (NYSE: PSFE), a leading payments platform, today announced its financial results for the second quarter of 2024. Second Quarter 2024 Financial Highlights (Metrics compared to second quarter of 2023, unless otherwise noted) Revenue of $439.9 million, increased 9%; increased 10% on a constant currency … [Read more...] about Paysafe Reports Second Quarter 2024 Results; Raises Full Year Revenue Outlook
Shift4 Announces Pricing of Offering of $1,100.0 Million of Senior Notes due 2032
CENTER VALLEY, Pa.--(BUSINESS WIRE)--$FOUR--Shift4 Payments, Inc. (NYSE: FOUR), a leader in integrated payments and commerce technology, today announced that its subsidiaries, Shift4 Payments, LLC (“Shift4”) and Shift4 Payments Finance Sub, Inc., have priced an offering of $1,100.0 million aggregate principal amount of 6.750% senior notes due 2032 (the “Notes”). The Notes were … [Read more...] about Shift4 Announces Pricing of Offering of $1,100.0 Million of Senior Notes due 2032
Cardea Successfully Closes $15 Million Convertible Note Financing
ATLANTA--(BUSINESS WIRE)--Cardea Corporate Holdings Inc. (“Cardea” or the “Company”), an emerging global asset management firm, today announced the closing of a $15 million convertible note financing round. The funds raised will be used to further accelerate the Company’s growth through strategic acquisitions and technological infrastructure enhancements. The oversubscribed … [Read more...] about Cardea Successfully Closes $15 Million Convertible Note Financing
eClinical Solutions Strategic Business Report 2024: Market to Grow by $11.9 Billion by 2030 – Rise in Clinical Trials Powers Growth, Rise in Pharmaceutical Sales to Drive Demand – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "eClinical Solutions - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for eClinical Solutions is estimated at US$10.0 Billion in 2023 and is projected to reach US$21.9 Billion by 2030, growing at a CAGR of 11.8% from 2023 to 2030. This comprehensive report provides an in-depth analysis of … [Read more...] about eClinical Solutions Strategic Business Report 2024: Market to Grow by $11.9 Billion by 2030 – Rise in Clinical Trials Powers Growth, Rise in Pharmaceutical Sales to Drive Demand – ResearchAndMarkets.com